Patients with diabetic kidney disease (DKD) and anemia have no worse, and possibly better, cardiovascular outcomes from finerenone treatment.

Updated, longer-term results from the COMMANDS trial show a promising trend toward improved overall survival with ...

New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

Japan: Researchers have found in a recent multicenter, open-label, single-arm study that Ferric citrate hydrate (FCH) ...

Adding niraparib to abiraterone acetate and prednisone may help slow cancer growth for patients with metastatic ...

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

JNJ-79635322 shows favorable responses and manageable safety in BCMA/GPRC5D-naïve patients with relapsed/refractory multiple ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.

The global sales of anemia treatment are estimated to be worth USD 12,287.3 million in 2025 and are anticipated to reach a value of USD 23,903.5 million by 2035. Sales are projected to rise at a CAGR ...

Akebia Therapeutics had a strong US launch of Vafseo and Q1 revenues signal robust demand, but near-term profitability ...

QRIS HEALTH, one of Delhi NCR's trusted diagnostic labs, is excited to introduce its brand-new mobile app for both Android ...